Abstract
Introduction: Hax-1, the hematopoietic cell-specific protein-associated protein X-1, is an inhibitor of apoptosis, which has been implicated in severe congenital neutropenia (SCN), neurological disorders and cancer. Hax-1 over-expression, as found in numerous types of cancer, results in resistance to granzyme B and caspase-3 and stabilizes the X-linked inhibitor of apoptosis, whereas its absence or knockdown promotes apoptosis. Hax-1 is bound to the cytosolic faces of mitochondria and the endoplasmic reticulum (ER). Interestingly, numerous viral proteins, including the classical swine fever virus N-terminal protease (Npro) and human immunodeficiency virus Vpr, interact with Hax-1 and disrupt its normal localization pattern. Recent findings have demonstrated that the localization to the ER allows Hax-1 to modulate calcium signaling via interactions with polycystin-2 and sarco(endo)plasmic reticulum calcium transport ATPase 2 (SERCA2).
Areas covered: This review discusses how the interaction of Hax-1 with calcium-handling proteins could dominate over its other roles in apoptosis, since Hax-1 no longer blocks apoptosis on over-expression of SERCA2.
Expert opinion: To facilitate pharmacological interference with the apoptosis-regulating functions of this protein, a better understanding of the Hax-1 intracellular targeting and protein-protein interactions is needed. Such an improved understanding would allow the generation of small molecule inhibitors that interfere with apoptosis-modulating functions of Hax-1 as seen in SCN.
Acknowledgments
I thank Ing-Swie Goping and Luca Pellegrini for critically reading the manuscript. Research in the Simmen lab is supported by Alberta Cancer Foundation grant #25018, NSERC grant 386757 – 2010, CCSRI grant 2010 – 700306 and AHFMR scholarship 200500396.
Notes
This box summarizes key points contained in the article.